CTOs on the Move

Johnson and Johnson Health Care Systems

www.jjhcs.com

 
Johnson & Johnson Health Care Systems Inc. (JJHCS) provides contracting, supply chain, business services, and strategic solutions to customers and commercial intermediaries of U.S.-based Johnson & Johnson (J&J) companies, including hospital systems, health plans, distributors, wholesalers, purchasing organizations, government payer programs, and government healthcare institutions in the U.S. JJHCS also engages with customers to provide streamlined supply chain services for our products that seamlessly integrate with customer operations, address shared evolving market challenges to value-based care, and develop innovative solutions that improve patient care and access.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.jjhcs.com
  • 425 Hoes Lane
    Piscataway Township, NJ USA 08854
  • Phone: 732.562.0177

Executives

Name Title Contact Details

Similar Companies

InnoTraction

InnoTraction is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TCP Reliable

TCP Reliable is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. TCP Reliable is based in Edison, NJ. You can find more information on TCP Reliable at www.tcpreliable.com

Cesca Therapeutics

We are at the cutting-edge of medical development – and through our advanced clinical trials, novel medical device development and in-house cellular manufacturing and quality control expertise, we intend to lead the industry. We are uniquely positioned and expect to maintain our leadership position though active collaborations with physicians, researchers, hospitals and blood banks on a wide range of clinical, cell-based approaches to medical treatment.

RBC Product Development

RBC Product Development is a Lenexa, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.